Microscale culture of human liver cells for drug development
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tissue function depends on hierarchical structures extending from single cells ( approximately 10 microm) to functional subunits (100 microm-1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved and have the advantages of miniaturization. Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity. We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, hepatic models that utilize conventional 2D mono-and co-cultures of normal and diseased human cells fail to mimic the complex threedimensional (3D) in vivo microenvironment and extracellular matrix (ECM) support [16,19,20].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [16]
In the citing paper
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009”
From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Khetani and Bhatia, 2008
Citations
Cites
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“Over the last decade, microtechnology tools have emerged to probe biomedical phenomena at relevant length scales and to miniaturize and parallelize biomedical assay”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Soft Lithography in Biology and Biochemistry
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X., & Ingber, D. E. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.335 · Cited by 2,607 · cited 1×
“Our approach incorporates 'soft lithography' techniques, using reusable, elastomeric molds of microfabricated structures to overcome limitations of photolithograph”
MethodIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 1×
“The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicit”
BackgroundGenome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“Although hepatocarcinoma-derived cell lines and immortalized hepatocytes can be reproducible and inexpensive, they display abnormal levels of liver-specific function”
BackgroundHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Cited by
Items 601–700 of 1,000
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Ortega‐Prieto, A. M., Skelton, J. K., Cherry, C. J., Briones-Orta, M. A., Hateley, C., & Dorner, M. (2019) · Journal of Visualized Experiments · doi:10.3791/58333 · Cited by 28
Microfluidic confinement enhances phenotype and function of hepatocyte spheroids
Choi, J. H., Loarca, L., de Hoyos‐Vega, J. M., Dadgar, N., Loutherback, K., Shah, V. H., Stybayeva, G., & Revzin, A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00094.2020 · Cited by 28
Current status of hepatocyte-like cell therapy from stem cells
Saito, Y., Ikemoto, T., Morine, Y., & Shimada, M. (2020) · Surgery Today · doi:10.1007/s00595-020-02092-6 · Cited by 28
Park, S., Nguyen, T., la Guillaume, É. B. À., Sackett, D. L., Garmendia‐Cedillos, M., Pursley, R. H., Boccara, C., & Gandjbakhche, A. (2021) · Biomedical Optics Express · doi:10.1364/boe.436330 · Cited by 28
Lentiviral microarrays for real-time monitoring of gene expression dynamics
Tian, J., Alimperti, S., Lei, P., & Andreadis, S. T. (2010) · Lab on a Chip · doi:10.1039/c003153d · Cited by 28
Sugiura, S., Cha, J. M., Yanagawa, F., Zorlutuna, P., Bae, H., & Khademhosseini, A. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1843 · Cited by 28
“Microfabrication technologies have been used for generating patterned co-cultures for controlling intercellular interaction in the 2Dmicroenvironment (Khetani and Bhatia, 2008; Trkov et al., 2010; Kaji et al., 2011).”
MethodNanofabricated Collagen-Inspired Synthetic Elastomers for Primary Rat Hepatocyte Culture
Bettinger, C. J., Kulig, K. M., Vacanti, J. P., Langer, R., & Borenstein, J. T. (2008) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0134 · Cited by 28
“Hepatic tissue engineering is of particular interest for a variety of applications, including bioartificial liver optimization, in vitro toxicity models, 1 and cell-based therapeutic tissue engineering devices.”
Rodent model of metabolic dysfunction‐associated fatty liver disease: a systematic review
Cui, X., Li, H., Li, L., Xie, C., Gao, J., Chen, Y., Zhang, H., Hao, W., Fu, J., & Guo, H. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16749 · Cited by 27
Ware, B. R., McVay, M., Sunada, W. Y., & Khetani, S. R. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx059 · Cited by 27
“…Institute (Cambridge, Massachusetts) or the University of Illinois at Chicago Core Genomics Facility where they were inspected for quality, hybridized to Affymetrix GeneChip Human Genome U133 Plus 2.0 microarrays, and quantified using previously published protocols (Khetani and Bhatia, 2008).”
BackgroundMethodInfluentialSelf-citationThree‐dimensional patterning in biomedicine: Importance and applications in neuropharmacology
Singh, A. V., Gharat, T. P., Batuwangala, M., Park, B., Endlein, T., & Sitti, M. (2017) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33922 · Cited by 27
Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers
Amirghasemi, F., Adjei‐Sowah, E., Pockaj, B. A., & Nikkhah, M. (2021) · Annals of Biomedical Engineering · doi:10.1007/s10439-020-02704-9 · Cited by 27
Application of microfluidic chips in anticancer drug screening
Fan, X., Deng, Z.-F., Yan, Y., Vé, O., Shypko, A., Orel, V. B., Ivanova, D., Pilarsky, C. P., Tang, J. P., Chen, Z., et al. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6484 · Cited by 27
Yang, S., Tseng, S., Chen, H.-P., Hsu, L., & Liu, C. (2013) · Lab on a Chip · doi:10.1039/c3lc50351h · Cited by 27
Modular microfluidic system as a model of cystic fibrosis airways
Skolimowski, M., Nielsen, M. W., Abeille, F., Skafte-Pedersen, P., Sabourin, D., Fercher, A., Papkovsky, D. B., Molin, S., Taboryski, R., Sternberg, C., et al. (2012) · Biomicrofluidics · doi:10.1063/1.4742911 · Cited by 27
McCarty, W. J., Usta, O. B., Luitje, M. E., Bale, S. S., Bhushan, A., Hegde, M., Golberg, I., Jindal, R., & Yarmush, M. L. (2014) · TECHNOLOGY · doi:10.1142/s2339547814500083 · Cited by 27
Prot, J. M., & Leclerc, É. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0480-5 · Cited by 27
Wei, J., Lu, J., Liu, Y., Yan, S., & Li, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02014c · Cited by 27
Tsukamoto, T., Sakai, E., Iizuka, S., Taracena-Gándara, M., Sakurai, F., & Mizuguchi, H. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00222 · Cited by 27
Watari, R., Kakiki, M., Oshikata, A., Takezawa, T., Yamasaki, C., Ishida, Y., Tateno, C., Kuroda, Y., Ishida, S., & Kusano, K. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.521 · Cited by 27
Evaluating nanomedicine with microfluidics
He, Z., Ranganathan, N., & Li, P. (2018) · Nanotechnology · doi:10.1088/1361-6528/aae18a · Cited by 27
Technological advancements for the development of stem cell-based models for hepatotoxicity testing
Natale, A., Vanmol, K., Arslan, A., Vlierberghe, S. V., Dubruel, P., Erps, J. V., Thienpont, H., Buzgo, M., Boeckmans, J., Kock, J. D., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02465-y · Cited by 27
Ramsden, D., Tweedie, D., Chan, T. S., & Tracy, T. S. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057901 · Cited by 27
“, CYP3A4)? The extended period of stability of highly functional enzyme activity offered by the human HepatoPac system (Khetani and Bhatia, 2008) permitted alteration of levels of CYP3A4 by siRNA in situ to clearly demonstrate a change in activity of CYP2C9.”
BackgroundMethodResultInfluentialUse of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?
Abdel‐Aziz, T., Dhar, D. K., Newsome, P. N., Malagó, M., & Damink, S. W. M. O. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02530.x · Cited by 26
“Attempts at developing sophisticated culture systems may help solve this problem (65).”
BackgroundMicroscale technologies for regulating human stem cell differentiation
Cimetta, E., & Vunjak‐Novakovic, G. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214530369 · Cited by 26
Reddy, M. B., Bolger, M. B., Fraczkiewicz, G., Frari, L. D., Luo, L., Lukáčová, V., Mitra, A., Macwan, J. S., Mullin, J. M., Parrott, N. J., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091325 · Cited by 26
“Docci followed a systematic model building approach, leveraging intrinsic clearance measurements made with HepatoPac® [62], which is a micropatterned coculture of primary human hepatocytes with mouse fibroblasts.”
MethodKlammers, F., Goetschi, A., Ekiciler, A., Walter, I., Parrott, N. J., Fowler, S. M., & Umehara, K. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000765 · Cited by 26
“Each well in HepatoPac® plates has 75% surface area as fibroblasts and 25% surface area as hepatocytes (Khetani and Bhatia, 2008; Chan et al., 2019).”
Keeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity
Sanchez-Rubio, A., Jayawarna, V., Maxwell, E., Dalby, M. J., & Salmerón‐Sánchez, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202110 · Cited by 26
Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction
Wang, E., Andrade, M. J., & Smith, Q. (2023) · Biomicrofluidics · doi:10.1063/5.0172677 · Cited by 26
Multi‐photon structuring of native polymers: A case study for structuring natural proteins
Gebinoga, M., Katzmann, J., Fernekorn, U., Hampl, J., Weise, F., Klett, M., Läffert, A., Klar, T. A., & Schober, A. (2013) · Engineering in Life Sciences · doi:10.1002/elsc.201200152 · Cited by 27
Jensen, B. E. B., Edlund, K., & Zelikin, A. N. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.036 · Cited by 26
“Thus, advanced hepatic tissue engineering techniques rely on the organization of hepatocytes and secondary, co-cultured cells in an island-type of organization [48,49].”
BackgroundTorisawa, Y., Mosadegh, B., Cavnar, S. P., Ho, M., & Takayama, S. (2010) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2010.0305 · Cited by 26
In Vitro Micro-Tissue and -Organ Models for Toxicity Testing
Li, Z. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00503-1 · Cited by 26
Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models
Lee, S. W., Jung, D. J., & Jeong, G. S. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00245-9 · Cited by 26
“interactions between homotypic and heterotypic cell populations [12, 13].”
BackgroundMethodZhang, T., Chen, J. S., Zhang, Q., Dou, J., & Gu, N. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.01.030 · Cited by 26
Lin, C., & Khetani, S. R. (2017) · Current Protocols in Toxicology · doi:10.1002/cptx.23 · Cited by 26
“Additionally, PHH monolayers are known to display declining CYP450 activities within a few hours, while hepatic polarity doesn’t properly establish until 4-5 days following seeding (Bi, Kazolias, & Duignan, 2006; Khetani & Bhatia, 2008).”
BackgroundMethodSelf-citationWare, B. R., Liu, J. S., Monckton, C. P., Ballinger, K. R., & Khetani, S. R. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab018 · Cited by 25
Self-citationThe Convergence of Artificial Intelligence and Microfluidics in Drug Research and Development
Qiao, D., Li, H., Zhang, X., Chen, X., Jiang, Z., Zou, J., Zhao, D., Zhu, W., Qian, X. H., & Li, H. (2025) · Engineering · doi:10.1016/j.eng.2025.07.025 · Cited by 25
3-D Microwell Array System for Culturing Virus Infected Tumor Cells
Assal, R. E., Gurkan, U. A., Chen, P., Juillard, F., Tocchio, A., Chinnasamy, T., Beauchemin, C., Unluisler, S., Canikyan, S., Holman, A. R., et al. (2016) · Scientific Reports · doi:10.1038/srep39144 · Cited by 25
“D models 36,37 ; however, they have never been explored to culture virus-infected tumor cells.”
BackgroundMethodFowler, S. M., Brink, A., Cleary, Y., Günther, A., Heinig, K., Husser, C., Kletzl, H., Kratochwil, N. A., Mueller, L. A., Savage, M. E., et al. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000563 · Cited by 25
“HepatoPac® is a well-established long-term HH co-culture system, which can maintain viability and functional expression of DMEs for up to seven days (Khetani and Bhatia, 2008; Underhill and Khetani, 2018).”
BackgroundMethodLi, J., Diamante, G., Ahn, I. S., Wijaya, D., Wang, X., Chang, C. H., Ha, S. M., Immadisetty, K., Meng, H., Nel, A. E., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101652 · Cited by 25
A Neurospheroid‐Based Microrobot for Targeted Neural Connections in a Hippocampal Slice
Kim, E., Jeon, S., Yang, Y., Jin, C., Kim, J., Oh, Y., Rah, J., & Choi, H. (2023) · Advanced Materials · doi:10.1002/adma.202208747 · Cited by 25
Organotypic systems in drug metabolism and toxicity: challenges and opportunities
Dash, A., Blackman, B. R., & Wamhoff, B. R. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.693161 · Cited by 21
“In this review, we cite literature from several biotechnology research companies that are addressing this issue, including Hepregen [10,93], HemoShear [13,14], CellAsics [11], Hurel [8,95], Regenemed [82] and Zyoxel [9,40], and the advantages that these systems offer over standard systems is summarized in Table 1.”
BackgroundInfluentialEngineering Surface Adhered Poly(vinyl alcohol) Physical Hydrogels as Enzymatic Microreactors
Fejerskov, B., Jensen, B. E. B., Jensen, N. B. S., Chong, S., & Zelikin, A. N. (2012) · ACS Applied Materials & Interfaces · doi:10.1021/am3013467 · Cited by 25
Microtechnology‐based organ systems and whole‐body models for drug screening
Lee, S. H., Ha, S. K., Choi, I., Choi, N., Park, T. H., & Sung, J. H. (2016) · Biotechnology Journal · doi:10.1002/biot.201500551 · Cited by 25
“The field of microtechnology has recently expanded with the addition of several diverse areas, including microfabrication, microfluidics, and the design of reactors, all of which have allowed in vitro systems to mimic hepatic functions more closely than conventional in vitro systems [46, 47].”
BackgroundMicrofabricated Physiological Models for In Vitro Drug Screening Applications
Ugolini, G. S., Cruz‐Moreira, D., Visone, R., Redaelli, A. C. L., & Rasponi, M. (2016) · Micromachines · doi:10.3390/mi7120233 · Cited by 25
“In an earlier work by Khetain and Bhatia, hepatocytes and fibroblasts were co-cultured by means of microfabricated polydimethylsiloxane (PDMS) stencils (Figure 1) [41].”
Vishwakarma, S. K., Bardia, A., Lakkireddy, C., Raju, N., Paspala, S. A. B., Habeeb, M. A., & Khan, A. A. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.045 · Cited by 25
Docci, L., Parrott, N. J., Krähenbühl, S., & Fowler, S. M. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219831407 · Cited by 25
Nazari, M., Rashidi, S., & Esfahani, J. A. (2019) · Chemical Engineering Science · doi:10.1016/j.ces.2019.115335 · Cited by 25
Kinge, C. W., Bhoola, N. H., & Kramvis, A. (2020) · Viruses · doi:10.3390/v12030353 · Cited by 25
“Using a combination of microtechnology and tissue engineering techniques, Khetani and Bhatia [116] established a miniature-like multi-well culture system for human liver cells termed micropatterned co-cultured (MPCC) system.”
BackgroundMethodIn vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 26
Nanocarrier‐Based Drug Delivery Systems using Microfluidic‐Assisted Techniques
Alam, M. K. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300041 · Cited by 24
Complex in vitro models positioned for impact to drug testing in pharma: a review
Kang, S., Chen, E. C., Cifuentes, H., Co, J. Y., Cole, G., Graham, J. C., Hsia, I., Kiyota, T., Klein, J. A., Kroll, K. T., et al. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6933 · Cited by 25
“Furthermore, the incorporation of support cell types (e.g. stromal cells or non-parenchymal cells) via mixed or micropatterned co-cultures enhances the stability and function of hepatocytes or hepatocyte-like cells cultured in 2D [242, 243].”
Approaches for Minimizing Metabolic Activation of New Drug Candidates in Drug Discovery
Kumar, S., Mitra, K., Kassahun, K., & Baillie, T. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_19 · Cited by 24
Kitagawa, F., Takei, S., 今泉幸文, & Tabata, Y. (2012) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0166 · Cited by 24
“10 13 The control of cell cluster size is important because differentiation is affected by cell number and cell-to-cell contact.”
Artificial organs: Honey, I shrunk the lungs
Eisenstein, M. S. (2015) · Nature · doi:10.1038/519s16a · Cited by 24
Chu, Q., Zhao, Y., Shi, X.-E., Han, W., Zhang, Y., Zheng, X., & Zhu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13147-z · Cited by 24
Ueno, T., Utsumi, J., Toi, M., & Shimizu, K. (2015) · BioMed Research International · doi:10.1155/2015/960840 · Cited by 24
Manipulation of microparticles using surface acoustic wave in microfluidic systems: a brief review
Nam, J., Lim, H., & Shin, S. (2011) · Korea-Australia Rheology Journal · doi:10.1007/s13367-011-0031-5 · Cited by 24
A microfluidic cell co-culture platform with a liquid fluorocarbon separator
Brewer, B. M., Shi, M., Jon, F., Webb, D. J., & Li, D. (2014) · Biomedical Microdevices · doi:10.1007/s10544-014-9834-8 · Cited by 24
“Designs that use micropatterning of specific molecules on a substrate allow for selective attachment of specific cell types to pre-determined regions (Bhatia et al. 1997; Kane et al. 2006; Khetani and Bhatia 2008).”
BackgroundArakawa, H., Kamioka, H., Jomura, T., Koyama, S., Idota, Y., Yano, K., Kojima, H., & Ogihara, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00885 · Cited by 24
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
Thi, V. L. D., Wu, X., & Rice, C. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031799 · Cited by 24
3D Bioprinted Liver-on-a-Chip for Drug Cytotoxicity Screening
Huh, J., Parra, J. P. R. L. L., Copus, J. S., Kang, H., Bishop, C. E., Söker, S., Murphy, S. V., Shupe, T. D., Yoo, J. J., Lee, S. J., et al. (2023) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0212 · Cited by 23
Automated, spatio‐temporally controlled cell microprinting with polymeric aqueous biphasic system
Petrak, D., Atefi, E., Yin, L., Chilian, W. M., & Tavana, H. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.25100 · Cited by 23
“Material properties and selective surface adhesiveness transferred using microfabricated stencils or elastomeric stamps can indirectly guide cell adhesion and alignment in a 2D plane (Cho et al., 2008; Khademhosseini et al., 2004; Khetani and Bhatia, 2008; Paz et al., 2012).”
BackgroundGiri, S., Açıkgöz, A., Pathak, P., Gutschker, S., Kürsten, A., Nieber, K., & Bader, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22738 · Cited by 23
Microbioreactor design for 3‐D cell cultivation to create a pharmacological screening system
Fernekorn, U., Hampl, J., Weise, F., Augspurger, C., Hildmann, C., Klett, M., Läffert, A., Gebinoga, M., Weibezahn, K. F., Schlingloff, G., et al. (2011) · Engineering in Life Sciences · doi:10.1002/elsc.201000145 · Cited by 23
Stem cells and liver engineering
Ordovás, L., Park, Y., & Verfaillie, C. M. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.07.002 · Cited by 23
“Use of single-cell dimensions (10 µm) is ideal to study cellular communication to distinct local stimuli (Khetani and Bhatia, 2008) during hepatic differentiation.”
BackgroundSong, Y., Zhang, D., Lv, Y., Guo, X. W., Lou, R., Wang, S., Wang, X., Yu, W., & Ma, X. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.07.058 · Cited by 23
Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures
Davidson, M. D., & Khetani, S. R. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa003 · Cited by 23
Self-citationDocci, L., Umehara, K., Krähenbühl, S., Fowler, S. M., & Parrott, N. J. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00513-5 · Cited by 24
Three-Dimensional-Bioprinted Liver Chips and Challenges
Dabbagh, S. R., Ozdalgic, B., Mustafaoğlu, N., & Taşoğlu, S. (2022) · Applied Sciences · doi:10.3390/app12105029 · Cited by 23
Surface Functionalization for Protein and Cell Patterning
Colpo, P., Ruiz, A., Ceriotti, L., & Rossi, F. (2009) · Springer eBooks · doi:10.1007/10_2009_2 · Cited by 23
“Micropatterned cocultures have been shown to be valuable platforms for long term hepatocyte culture and for the miniaturization of hepatoxicity screening assays [11] .”
BackgroundFusing Tissue Engineering and Systems Biology Toward Fulfilling Their Promise
Cosgrove, B. D., Griffith, L. G., & Lauffenburger, D. A. (2008) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-008-0007-9 · Cited by 23
Overview of Tissue Engineering Concepts and Applications
Sarkar, D., Zhao, W., Schaefer, S., Ankrum, J. A., Teo, G. S. L., Pereira, M. N., Ferreira, L., & Karp, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-08-087780-8.00109-1 · Cited by 23
Advancements in in vitro hepatic models: application for drug screening and therapeutics
Damania, A., Jain, E., & Kumar, A. (2013) · Hepatology International · doi:10.1007/s12072-013-9490-8 · Cited by 23
“HepatoPac [24] Hepatocytes spotted on a chip surrounded by fibroblast High-throughput, co-culture is possible, useful for drug toxicity and cell-matrix interaction studies.”
BackgroundMethodEngineering Tissue with BioMEMS
Borenstein, J. T., & Vunjak‐Novakovic, G. (2011) · IEEE Pulse · doi:10.1109/mpul.2011.942764 · Cited by 23
“A softlithography-based approach has been established as a screening platform for liver toxicity, where heterotypic interactions between hepatocytes and fibroblasts are governed by patterns on stamped substrates [17].”
BackgroundAdvancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22
“Using the micropatterned co-cultures (MPCCs) approach pioneered by Bhatia’s group [175], the authors achieved precision placement of the HSCs around islands of hepatocytes.”
MethodAdvancing hepatotoxicity assessment: current advances and future directions
Kim, Y., Kim, Y., & Kim, Y. (2025) · Toxicological Research · doi:10.1007/s43188-025-00289-w · Cited by 23
“These cells were incorporated to better reflect the interactions between different cell types in the liver tissue and rec-reate the liver microenvironment [63–66].”
Prahl, L. S., Porter, C. M., Liu, J., Viola, J. M., & Hughes, A. J. (2023) · iScience · doi:10.1016/j.isci.2023.106657 · Cited by 22
“cue, while subsequent cells are added as backfill.(19) Other photolithographic methods such as digital micromirror device projection or direct laser writing afford high spatial resolution and dynamic control over ECM patterning.”
BackgroundLiu, Y., Wei, J., Lu, J., Lei, D., Yan, S., & Li, X. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.025 · Cited by 22
“The primary hepatocytes isolated from Lewis rats by a collagenase perfusion indicated albumin secretions varying from higher than 120 μg/10(6) cells/day to less than 10 μg/10(6) cells/day [23,40].”
BackgroundMethodInfluentialWu, J., Jie, M., Dong, X., Qi, H., & Lin, J. (2016) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7643 · Cited by 22
Lin, C., Romero, R., Sorokina, L. V., Ballinger, K. R., Place, L. W., Kipper, M. J., & Khetani, S. R. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36293 · Cited by 22
Self-citationDroplet-based microfluidics for cell encapsulation and delivery
Chen, R., Sun, Z., & Chen, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812659-2.00011-9 · Cited by 22
Numerical Investigations of Hepatic Spheroids Metabolic Reactions in a Perfusion Bioreactor
Sharifi, F., Firoozabadi, B., & Firoozbakhsh, K. K. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00221 · Cited by 22
“Oxygen Concentration Inlet oxygen concentration inside the medium is obtained via Henry’s law, which is relating dissolved oxygen concentration inside the medium to the oxygen partial pressure at 37C and atmospheric pressure condition (Barrett et al., 2006; Khetani and Bhatia, 2008):”
BackgroundMethodMilner, E., Ainsworth, M., McDonough, M., Stevens, B. D., Buehrer, J., Delzell, R., Wilson, C., & Barnhill, J. C. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100060 · Cited by 22
Hepatocyte cultures: From collagen gel sandwiches to microfluidic devices with integrated biosensors
de Hoyos‐Vega, J. M., Hong, H. J., Stybayeva, G., & Revzin, A. (2021) · APL Bioengineering · doi:10.1063/5.0058798 · Cited by 22
Maher, S. P., Crouse, R. B., Conway, A. J., Bannister, E. C., Achyuta, A. K. H., Clark, A. Y., Sinatra, F. L., Cuiffi, J. D., Adams, J. H., Kyle, D. E., et al. (2014) · Biomedical Microdevices · doi:10.1007/s10544-014-9877-x · Cited by 22
Andria, B., Bracco, A., Cirino, G., & Chamuleau, R. A. F. M. (2010) · Cell Medicine · doi:10.3727/215517910x519274 · Cited by 22
What gastroenterologists and hepatologists should know about organoids in 2019
Günther, C., Brevini, T., Sampaziotis, F., & Neurath, M. F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.02.020 · Cited by 22
“In vitro production of bona-fide hepatocytes could provide a unique platform for disease modeling and high-throughput drug screening [59,60].”
BackgroundAdvances and challenges in studying hepatitis C virus in its native environment
Sheahan, T. P., Jones, C. T., & Ploß, A. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.53 · Cited by 21
He, C., Lu, F., Liu, Y., Lei, Y., Wang, X., & Tang, N. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23504 · Cited by 21
“However, with the evolution and commercialization of microfluidic devices and in-vitro systems, the organ-on-a-chip field experienced a surge in research, thereby accounting for the subsequent exponential growth in related studies post-2014 [1,4,40,41].”
BackgroundYasar, O., Lan, S.-F., & Starly, B. (2009) · Biofabrication · doi:10.1088/1758-5082/1/4/045004 · Cited by 21
Perspective on the Application of Microphysiological Systems to Drug Transporter Studies
Caetano-Pinto, P., & Stahl, S. H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082750 · Cited by 21
“MPCC hepatocytes displayed enhanced P-gp and organic cation transporter 1 (OCT1) gene expression and bile canaliculi formation after 1 week, relative to nonMPCCs, as well as increased expression of key P450 enzymes up to 42 days (Khetani and Bhatia, 2008).”
BackgroundImproving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers
Mâncio-Silva, L., Fleming, H. E., Miller, A. B., Milstein, S., Liebow, A., Haslett, P. A. J., Sepp‐Lorenzino, L., & Bhatia, S. N. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.003 · Cited by 21
“…axes of liver metabolism and function and have been shown to reliably predict the hepatoxicity of FDA-approved and preclinical compounds (Ballard et al., 2016; Da-vidson et al., 2017; Khetani and Bhatia, 2008; Khetani et al., 2013; Lin and Khetani, 2017; Wang et al., 2010; Ware et al., 2017).”
Self-citationLong‐term maintenance of functional primary human hepatocytes using small molecules
Katsuda, T., Kawamata, M., Inoue, A., Yamaguchi, T., Abe, M., & Ochiya, T. (2019) · FEBS Letters · doi:10.1002/1873-3468.13582 · Cited by 21
Controlled Apoptosis of Stromal Cells to Engineer Human Microlivers
Chen, A. X., Chhabra, A., Song, H. G., Fleming, H. E., Chen, C. S., & Bhatia, S. N. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910442 · Cited by 21
Self-citationHafey, M. J., Houle, R., Tanis, K. Q., Knemeyer, I. W., Shang, J., Chen, Q., Baudy, A. R., Monroe, J. J., Sistare, F. D., & Evers, R. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000086 · Cited by 21
Liver-lobule-mimicking patterning via dielectrophoresis and hydrogel photopolymerization
Chen, Y.-S., Tung, C.-K., Dai, T.-H., Wang, X., Yeh, C., Fan, S., & Liu, C. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130159 · Cited by 21
Ramírez‐Flores, C. J., Perdomo, A. M. T., Gallego-López, G. M., & Knoll, L. J. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00025-22 · Cited by 21
“(180) was used as a platform for the Plasmodium liver stage by using cryopreserved he-”
MethodCell Patterning for Liver Tissue Engineering via Dielectrophoretic Mechanisms
Yahya, W. N. W., Kadri, N. A., & Ibrahim, F. (2014) · Sensors · doi:10.3390/s140711714 · Cited by 21
“(e) Soft lithography to fabricate hepatocytes micropatterning in a multiwell format [27].”
MethodModels for barrier understanding in health and disease in lab-on-a-chips
Ponmozhi, J., Dhinakaran, S., Kocsis, D., Iván, K., & Erdő, F. (2023) · Tissue Barriers · doi:10.1080/21688370.2023.2221632 · Cited by 20
“This review article describes a comparison of different types of liver-on-a-chip devices based on their culture format: static platforms 70 , gravity-driven platforms 71 , pump-driven 2D platforms 72 , membrane-based 2D platforms 73 , 3D mass culture in sinusoid mimetic 74–78 , 3D mass culture in…”
Background
Metadata
- Authors
- Khetani, S. R., & Bhatia, S. N.
- Affiliations
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatia, Sangeeta N
- Venue
- Nature Biotechnology
- Published
- 2007-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 120-126
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2023296392
- Cited by
- 1,219
- References
- 41
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 36 · 2023: 49 · 2022: 64 · 2021: 56 · 2020: 68 · 2019: 73 · 2018: 81 · 2017: 86 · 2016: 93 · 2015: 77 · 2014: 76 · 2013: 90 · 2012: 75
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- human liver cells, liver-on-a-chip, hepatotoxicity, drug development, phase I and II metabolism, canalicular transport, hepatocyte secretion, gene expression profiling, tissue engineering, microtechnology
- MeSH terms
- Biological Assay, Cells, Cultured, Equipment Design, Humans, Miniaturization, Drug Design, Flow Injection Analysis, Cell Culture Techniques, Equipment Failure Analysis, Hepatocytes, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.